{
    "2018-09-03": [
        [
            {
                "time": "2018-07-15",
                "original_text": "An Update on Becton Dickinson's Medical Segments",
                "features": {
                    "keywords": [
                        "Becton Dickinson",
                        "Medical Segments",
                        "Update"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-30",
                "original_text": "Assessing Eli Lilly's Human Pharmaceutical Segment in Q2 2018",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Human Pharmaceutical",
                        "Q2 2018",
                        "Assessing"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}